Fan, Yong http://orcid.org/0000-0003-4813-7017
Støving, René Klinkby
Berreira Ibraim, Samar
Hyötyläinen, Tuulia
Thirion, Florence http://orcid.org/0000-0002-2310-5548
Arora, Tulika http://orcid.org/0000-0001-8821-8191
Lyu, Liwei http://orcid.org/0000-0002-7387-8557
Stankevic, Evelina http://orcid.org/0000-0002-6433-6975
Hansen, Tue Haldor http://orcid.org/0000-0001-5948-8993
Déchelotte, Pierre http://orcid.org/0000-0001-5224-6166
Sinioja, Tim
Ragnarsdottir, Oddny
Pons, Nicolas
Galleron, Nathalie
Quinquis, Benoît
Levenez, Florence
Roume, Hugo http://orcid.org/0000-0003-2995-242X
Falony, Gwen
Vieira-Silva, Sara http://orcid.org/0000-0002-4616-7602
Raes, Jeroen http://orcid.org/0000-0002-1337-041X
Clausen, Loa http://orcid.org/0000-0002-4559-8347
Telléus, Gry Kjaersdam
Bäckhed, Fredrik
Oresic, Matej http://orcid.org/0000-0002-2856-9165
Ehrlich, S. Dusko
Pedersen, Oluf http://orcid.org/0000-0002-3321-3972
Article History
Received: 23 June 2022
Accepted: 3 March 2023
First Online: 17 April 2023
Competing interests
: F.B. is a shareholder in Implexion Pharma. The other authors declare no competing interests.